Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Guided ESB vs TPVB for Acute Thoracic Herpes Zoster
NCT04656821Phase 4Unknown
- Sponsor
- Tanta University
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine and dexamethasone in herpes zoster (HZ) (3 arms), sponsored by Tanta University. Primary endpoint: Incidence of post herpetic neuralgia at 3 months. Status: unknown.
02
Drugs
bupivacainedexamethasone
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT04656821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04656821.